Cancers Treated:
Specializing In:
- Abdominal imaging
- Magnetic resonance imaging
- Computed tomography
- Ultrasound
Positions
Roswell Park Comprehensive Cancer Center
- Assistant Professor of Oncology
- Department of Diagnostic and Interventional Radiology
Background
Education and Training
- 2015-2019 - DO - University of New England College of Osteopathic Medicine, Biddeford, ME
- 2012-2015 - MS - Cancer Sciences, State University of New York at Buffalo, Roswell Park Division, Buffalo, NY
Residency
- 2020-2024 - Diagnostic Radiology - Strong Memorial Hospital, University of Rochester Medical Center, Rochester, NY
- 2019-2020- Internship, Internal Medicine - Sisters of Charity Hospital, State University of New York at Buffalo, Buffalo, NY
Fellowship
- 2024-2025 - Abdominal/Body Imaging Fellowship - Strong Memorial Hospital, University of Rochester Medical Center, Rochester, NY.
Professional Memberships
- Radiological Society of North America
- American College of Radiology
- American Roentgen Ray Society
Publications
1. Bothwell KD, Ling FS, Ambrosini R, Baran TM, Lorca MC, Chaturvedi A. Standardized Criteria for Identification of Cardiac Tamponade on Non-Electrocardiogram-gated Computed Tomography: Correlation With Echocardiographic Findings. J Thorac Imaging. 2023 Jul 1;38(4):W44-W51. doi: 10.1097/RTI.0000000000000688. Epub 2022 Dec 13. PMID: 36546839.
2. Bothwell KD, Shaurova T, Merzianu M, Suresh A, Kuriakose MA, Johnson CS, Hershberger PA, Seshadri M. Impact of Short-term 1,25-Dihydroxyvitamin D3 on the Chemopreventive Efficacy of Erlotinib against Oral Cancer. Cancer Prev Res (Phila). 2015 Sep;8(9):765-76. doi: 10.1158/1940-6207.CAPR-14-0454. Epub 2015 Jun 22. PMID: 26100522; PMCID: PMC4560661.
3. Bothwell KD, Folaron M, Seshadri M. Preclinical Activity of the Vascular Disrupting Agent OXi4503 against Head and Neck Cancer. Cancers (Basel). 2016 Jan 7;8(1):11. doi: 10.3390/cancers8010011. PMID: 26751478; PMCID: PMC4728458.
4. Aalinkeel R, Nair B, Chen CK, Mahajan SD, Reynolds JL, Zhang H, Sun H, Sykes DE, Chadha KC, Turowski SG, Bothwell KD, Seshadri M, Cheng C, Schwartz SA. Nanotherapy silencing the interleukin-8 gene produces regression of prostate cancer by inhibition of angiogenesis. Immunology. 2016 Aug;148(4):387-406. doi: 10.1111/imm.12618. PMID: 27159450; PMCID: PMC4948039.